Ciltacabtagene autoleucel,Pomalidomide,Bortezomib,Dexamethasone,Daratumumab
Janssen
['cartitude-4', '3 car,(-23 care)', 'cartitude']
excited to see the phase 3 cartitude-4 results in and being presented here at #asco23. #mycompany 
VP of Oncology Global Medical Affairs at Janssen, J&J

Scientist focused on bringing new treatment options for pts with cancer. Tweets/views shared are my own